Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)

PHASE3CompletedINTERVENTIONAL

Enrollment

395

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions

Obstructive Sleep ApneaHypopnea

Interventions

DRUG

Armodafinil 250 mg/day

Armodafinil 250 mg once daily in the morning

DRUG

Armodafinil 150 mg/day

Armodafinil 150 mg once daily in the morning

DRUG

Placebo

Matching placebo tablets once daily in the morning